PerkinElmer's Oxford Immunotec receives U.S. FDA approval fo

PerkinElmer’s (NYSE: PKI) Oxford Immunotec today announced the U.S. Food and Drug Administration (FDA) has approved the use of the T-Cell Select™ reagent kit for the automation of its T-SPOT®.TB test workflow for in vitro diagnostic (IVD) use by certified laboratories.

Related Keywords

China , United States , South Korea , Oxford Immunotec , Oxford Immunotecoct , Phill Keefe , Perkinelmer Oxford Immunotec , Instagram , Linkedin , Twitter , Drug Administration , Youtube , Perkinelmer , National Medical Products Administration , Facebook , Ministry Of Food , From Oxford Immunotecoct , T Cell Select , Cell Select , Drug Safety , Cell , T Cell , Tuberculosis , Utomation , Flood , Iagnostic , Wood , N Vitro , Dvd ,